3-iodobenzylguanidine has been researched along with Autosomal Dominant Cerebellar Ataxia, Type II in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carotenuto, R; Cuocolo, A; De Leva, MF; De Michele, G; De Rosa, A; Filla, A; Fiumara, G; Maddaluno, G; Pappatà , S; Pellegrino, T; Petretta, M | 1 |
1 other study(ies) available for 3-iodobenzylguanidine and Autosomal Dominant Cerebellar Ataxia, Type II
| Article | Year |
|---|---|
Reduced cardiac 123I-metaiodobenzylguanidine uptake in patients with spinocerebellar ataxia type 2: a comparative study with Parkinson's disease.
Topics: 3-Iodobenzylguanidine; Adult; Biological Transport; Female; Heart; Humans; Male; Middle Aged; Myocardium; Parkinson Disease; Radionuclide Imaging; Spinocerebellar Ataxias; Sympathetic Nervous System; Young Adult | 2013 |